Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the final report of the Infected Blood Inquiry, published on 20 May 2024, whether any ongoing access to (a) patient notes, (b) tissue samples and (c) post‑mortem material is being carried out under (i) public health legislation and (ii) other regulatory powers.

Given the long-running nature of the infected blood scandal, not all medical records will still be available, and eligibility for compensation will be determined based on the balance of probabilities.

The Infected Blood Compensation Authority (IBCA) will try to get as much information, including medical records and information about an applicant’s condition, from organisations who already have this information. This should mean those claiming will be asked for the least amount of information possible.

The IBCA will provide assistance to those who believe their medical records have been lost or destroyed. The role of the IBCA’s claim managers includes helping individuals who are claiming to gather information, including medical evidence where available, to support their claim.

In July 2025, the Permanent Secretary of the Cabinet Office wrote to the chairs of the Public Accounts and Public Administration and Constitutional Affairs Committees to set out the measures being taken to prioritise faster payments to victims of the infected blood scandal. One of these measures is to use the powers in the Victims and Prisoners Act to get records from the Infected Blood Inquiry, and using testimony to contribute to the assessment of proof of infection.

Organisations that remove, store, and use human tissue for some types of health research, medical treatment, post-mortem examination, education and training, and for display in public, are independently regulated by the Human Tissue Authority.